文献速递妇科

评估经尿道导管自行拔除的医疗资源利用与可行性

Assessing Health Care Utilization and Feasibility of Transurethral Catheter Self-Discontinuation.
PubMed 文献 · Obstet Gynecol · 2023-03-09

前瞻性观察队列研究纳入140例接受门诊良性妇科或泌尿妇科手术的女性,术后第0天排尿试验失败者于术后第1天上午6时按指导自行剪断导管并记录6小时排尿量。48例自行拔除导管者中81.3%(95%CI 68.1-89.8%)术后第1天居家排尿试验成功,无不良事件;术后第0天排尿试验失败者办公室电话/信息更多(3 vs 2,P<.001),术后第1天排尿试验失败者办公室就诊更多(2 vs 1,P<.001)。

要点

  • 术后第1天居家自行拔除导管可行,48例中81.3%排尿试验成功且无不良事件。
  • 术后第0天排尿试验失败者办公室电话/信息更多(3 vs 2,P<.001)。
  • 术后第1天排尿试验失败者办公室就诊更多(2 vs 1,P<.001)。

核心结论

  • 导管自行拔除是术后第1天办公室排尿试验的可行替代方案,后续尿潴留率低,且本先导研究未见不良事件。

研究设计与样本

  • 前瞻性观察队列研究,纳入2021年8月至2022年1月在一家学术诊所因良性指征接受门诊泌尿妇科或微创妇科手术的女性140例。

主要发现

  • 140例中50例(35.7%)术后第0天排尿试验失败,其中48例(96%)于术后第1天执行导管自行拔除。
  • 48例术后第1天自行拔除导管者中81.3%(95%CI 68.1-89.8%)居家排尿试验成功,成功者中94.5%(95%CI 83.1-98.6%)无需额外导尿。
  • 术后第0天排尿试验失败者较成功者办公室电话/信息更多(3 vs 2,P<.001),术后第1天排尿试验失败者较成功者办公室就诊更多(2 vs 1,P<.001)。
  • 术后第0天或第1天排尿试验成功者与失败者之间,急诊就诊或术后并发症无差异。
  • 术后第0天排尿试验失败者年龄更大,且更可能接受阴道子宫切除术或脱垂修复术;术后第1天排尿试验失败者年龄大于成功者。

临床怎么用

  • 作者认为,在晚期良性妇科和泌尿妇科手术后,导管自行拔除是术后第1天办公室排尿试验的可行替代方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the rates of health care utilization (office messages or calls, office visits, and emergency department [ED] visits) and postoperative complications within 30 days after surgery between patients with successful voiding trials on postoperative day 0 and those with unsuccessful voiding trials on postoperative day 0 and between patients with successful and unsuccessful voiding trials on postoperative day 1. Secondary objectives were to identify risk factors for unsuccessful voiding trials on postoperative days 0 and 1 and to explore the feasibility of catheter self-discontinuation by assessing for any complications associated with at-home catheter self-discontinuation on postoperative day 1. METHODS: This study was a prospective observational cohort study of women undergoing outpatient urogynecologic or minimally invasive gynecologic surgery for benign indications at one academic practice from August 2021 to January 2022. Enrolled patients with unsuccessful immediate postoperative voiding trials on postoperative day 0 performed catheter self-discontinuation by cutting their catheter tubing per instructions at 6 am on postoperative day 1 and recording their voided volumes over the subsequent 6 hours. Patients who voided less than 150 mL underwent a repeat voiding trial in the office. Demographics, medical history, perioperative outcomes, and number of postoperative office calls or visits and ED visits within 30 days were collected. RESULTS: Of the 140 patients who met inclusion criteria, 50 patients (35.7%) had unsuccessful voiding trials on postoperative day 0, and 48 of these 50 (96%) performed catheter self-discontinuation on postoperative day 1. Two patients did not perform catheter self-discontinuation on postoperative day 1: One had her catheter removed in the ED on postoperative day 0 during an ED visit for pain control, and the other performed catheter self-discontinuation off protocol at home on postoperative day 0. There were no adverse events associated with at-home postoperative day 1 catheter self-discontinuation. Of the 48 patients who performed catheter self-discontinuation on postoperative day 1, 81.3% (95% CI 68.1-89.8%) had successful postoperative day 1 at-home voiding trials, and 94.5% (95% CI 83.1-98.6%) of those with successful voiding trials did not require additional catheterization. Patients with unsuccessful postoperative day 0 voiding trials had more office calls and messages (3 vs 2, P <.001) and those with unsuccessful postoperative day 1 voiding trials attended more office visits (2 vs 1, P <.001) compared with those with successful postoperative day 0 or 1 voiding trials, respectively. There was no difference in ED visits or postoperative complications between patients with successful voiding trials on postoperative day 0 or 1 and those with unsuccessful voiding trials on postoperative day 0 or 1. Patients with unsuccessful postoperative day 0 voiding trials were older and more likely to have undergone vaginal hysterectomy or prolapse repair than those with successful postoperative day 0 voiding trials. Patients with unsuccessful postoperative day 1 voiding trials were older than those with successful postoperative day 1 voiding trials. CONCLUSION: Catheter self-discontinuation is a feasible alternative to in-office voiding trials on postoperative day 1 after advanced benign gynecologic and urogynecologic surgery, with low rates of subsequent retention and no adverse events seen in our pilot study.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Davenport A, Li Y, Melvin E, et al. Assessing Health Care Utilization and Feasibility of Transurethral Catheter Self-Discontinuation. Obstet Gynecol. 2023. PMID: 36897148. doi:10.1097/AOG.0000000000005105

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。